Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

HNSN Insider Trading

HNSN | Market Equity

Comprehensive Trading Performance Summary

The investment history of corporate insiders at HNSN provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2016-06-10 21:23 2016-06-08 Vance Cary Guy Director, Officer - President and CEO SELL $3.99 596 $2,378 15,492 -3.7%
2016-06-10 21:15 2016-06-08 Sheahan Brian Officer - VP, Regulatory, Clinical & QA SELL $3.99 166 $662 5,406 -3.0%
2016-03-09 20:42 2016-03-07 Sheahan Brian Officer - VP, Regulatory, Clinical & QA SELL $2.51 161 $404 5,215 -3.0%
2016-02-18 00:38 2016-02-12 Sheahan Brian Officer - VP, Regulatory, Clinical & QA SELL $2.34 3,472 $8,124 5,019 -40.9%
2016-02-18 00:37 2016-02-12 Cathcart Robert O Officer - SVP, Global Sales SELL $2.34 284 $665 721 -28.3%
2016-02-18 00:35 2016-02-12 Guido Joseph James Officer - VP, Marketing & Business Dev SELL $2.34 2,000 $4,680 4,524 -30.7%
2016-02-18 00:32 2015-06-24 Vance Cary Guy Director, Officer - President and CEO OPT+S $7.85 3,338 $26,210 14,597 0.0%
2015-05-19 04:25 2015-05-12 FEINBERG LARRY N 10% owner BUY $0.65 18,890,210 $12,278,637 4,928,478 +100.0%
2015-05-16 02:01 2015-05-12 Schuler Family Foundation 10% owner BUY $0.00 23,612,250 $0 23,612,250 +100.0%
2015-05-15 04:42 2015-05-12 FEINBERG LARRY N 10% owner BUY $0.65 18,888,681 $12,277,643 4,928,288 +100.0%
2015-03-11 19:57 2015-03-09 Schuler Family Foundation 10% owner BUY $650.00 23,077 $15,000,050 23,077 +100.0%
2014-12-11 00:50 2014-12-10 Yared Nadim Director BUY $0.65 15,000 $9,750 46,972 +46.9%
2014-12-04 00:14 2014-12-03 Sutton William Mitchell Officer - Chief Operating Officer BUY $0.75 25,000 $18,805 25,000 +100.0%
2014-11-13 01:42 2014-11-12 Vance Cary Guy Director, Officer - President and CEO BUY $0.83 75,000 $61,995 75,000 +100.0%
2014-03-13 02:54 2014-03-11 EAGLE MICHAEL L Director BUY $2.29 10,000 $22,900 16,250 +160.0%
2014-03-06 00:32 2014-03-03 Jacob Rita V. Officer - VP Training & Clinical Affairs SELL $2.35 35,589 $83,634 0 -100.0%
2014-03-05 01:58 2014-02-28 Leonard Susan Officer - Vice President, Human Resource SELL $2.37 20,415 $48,398 0 -100.0%
2014-02-28 04:34 2014-02-27 Sutton William Mitchell Officer - Chief Operating Officer SELL $2.37 14,959 $35,453 0 -100.0%
2014-02-28 04:36 2014-02-26 MARIANI PETER J Officer - Chief Financial Officer SELL $2.30 43,435 $99,901 0 -100.0%
2013-08-09 00:03 2013-08-08 FEINBERG LARRY N 10% owner BUY $1.23 8,101,810 $9,965,226 1,587,860 +100.0%
2013-08-02 03:23 2013-07-30 Hykes Kevin Director BUY $1.23 28,455 $35,000 35,955 +379.4%
2013-08-02 03:22 2013-07-30 Yared Nadim Director BUY $1.23 12,195 $15,000 15,195 +406.5%
2013-08-02 03:20 2013-07-30 Newman Stephen L Director BUY $1.23 81,301 $100,000 88,301 +1,161.4%
2013-08-02 03:08 2013-07-30 BOWEN MARJORIE L. Director BUY $1.23 55,708 $68,521 55,708 +100.0%
2013-08-02 03:35 2013-07-30 ROHN WILLIAM R Director BUY $1.23 100,000 $123,000 110,000 +1,000.0%
2013-08-02 03:19 2013-07-30 WEINSTEIN WILL K Director BUY $1.23 869,825 $1,069,885 869,825 +100.0%
2013-05-16 02:57 2013-05-13 Yared Nadim Director BUY $1.66 3,000 $4,977 3,000 +100.0%
2013-05-15 23:36 2013-05-13 Hykes Kevin Director BUY $1.67 7,500 $12,500 7,500 +100.0%
2013-05-15 23:35 2013-05-13 LOWE CHRISTOPHER P. Director BUY $1.52 12,500 $19,000 22,500 +125.0%
2013-05-15 23:35 2013-05-13 Newman Stephen L Director BUY $1.66 7,000 $11,631 7,000 +100.0%
2013-05-15 23:31 2013-05-13 EAGLE MICHAEL L Director BUY $1.66 6,250 $10,353 6,250 +100.0%
2013-05-16 00:52 2013-05-13 FEINBERG LARRY N 10% owner BUY $1.52 37,363 $56,792 338,206 +12.4%
2013-05-15 23:33 2013-05-13 ROHN WILLIAM R Director BUY $1.53 10,000 $15,284 10,000 +100.0%
2013-03-13 00:47 2013-03-08 FEINBERG LARRY N 10% owner BUY $2.15 65,900 $141,599 300,843 +28.0%
2013-03-07 14:03 2013-03-05 Schembri Frank M. Jr. Officer - Vice President Manufacturing SELL $2.24 5,767 $12,892 7,092 -44.8%
2013-03-07 14:02 2013-03-05 Jacob Rita V. Officer - VP Training & Clinical Affairs SELL $2.24 6,296 $14,074 21,959 -22.3%
2013-03-07 14:01 2013-03-05 Bruguera Carolyn M Officer - VP, General Counsel SELL $2.24 7,408 $16,560 9,110 -44.8%
2013-03-07 14:01 2013-03-05 Guido Joseph James Officer - See Remarks SELL $2.24 4,802 $10,763 5,906 -44.8%
2013-03-07 14:02 2013-03-05 BARCLAY BRUCE Director, Officer - President and CEO SELL $2.24 19,194 $43,020 182,264 -9.5%
2013-03-07 14:02 2013-03-05 MARIANI PETER J Officer - Chief Financial Officer SELL $2.24 7,424 $16,600 21,205 -25.9%
2013-03-02 01:19 2013-02-27 FEINBERG LARRY N 10% owner BUY $2.23 95,353 $212,570 1,383,038 +7.4%
2013-02-27 00:41 2013-02-21 FEINBERG LARRY N 10% owner BUY $2.33 35,000 $81,550 1,365,750 +2.6%
2013-01-25 02:26 2013-01-22 FEINBERG LARRY N 10% owner BUY $2.53 27,660 $69,858 1,359,850 +2.1%
2013-01-16 02:05 2013-01-11 FEINBERG LARRY N 10% owner BUY $2.20 74,191 $163,502 1,355,250 +5.8%
2013-01-01 00:30 2012-12-27 FEINBERG LARRY N 10% owner BUY $2.00 29,300 $58,600 1,341,850 +2.2%
2012-12-27 01:55 2012-12-21 FEINBERG LARRY N 10% owner BUY $2.15 25,000 $53,750 1,336,950 +1.9%
2012-12-13 01:42 2012-12-10 FEINBERG LARRY N 10% owner BUY $2.25 69,901 $157,284 1,332,750 +5.5%
2012-12-01 01:44 2012-11-26 FEINBERG LARRY N 10% owner BUY $2.20 66,780 $146,742 1,320,950 +5.3%
2012-11-17 01:27 2012-11-14 FEINBERG LARRY N 10% owner BUY $2.16 139,922 $301,532 1,310,150 +12.0%
2012-11-17 01:27 2012-11-14 FEINBERG LARRY N 10% owner SELL $2.18 69,922 $152,430 0 -100.0%
SHOW ENTRIES

How to Interpret $HNSN Trades

Not every insider transaction in HNSN is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HNSN shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for HNSN

Insider activity data for HNSN is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HNSN, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.